Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Standard Chemotherapy Versus Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer

NCT03949283 is registered in ClinicalTrials.gov with Cordgenics, LLC as lead sponsor.

NCT NCT03949283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03949283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Standard Chemotherapy Versus Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer
Lead sponsor
Cordgenics, LLC
Phase
Phase 3
Overall status
Active, not recruiting
Start date
July 26, 2019
Completion date
December 30, 2024
Enrollment
150 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

platinum-resistant ovarian cancer, recurrent ovarian carcinoma